Pro-Dex, Inc. (PDEX)
65.31
+0.59
(+0.91%)
USD |
NASDAQ |
Jun 25, 16:00
65.31
0.00 (0.00%)
After-Hours: 16:03
Pro-Dex Free Cash Flow : 6.969M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2026 | 6.969M |
| December 31, 2025 | 6.022M |
| September 30, 2025 | -2.172M |
| June 30, 2025 | -2.928M |
| March 31, 2025 | -1.749M |
| December 31, 2024 | 1.637M |
| September 30, 2024 | 6.406M |
| June 30, 2024 | 5.216M |
| March 31, 2024 | 4.778M |
| December 31, 2023 | 3.021M |
| September 30, 2023 | 2.04M |
| June 30, 2023 | 4.488M |
| March 31, 2023 | -1.635M |
| December 31, 2022 | -3.831M |
| September 30, 2022 | -1.645M |
| June 30, 2022 | -2.518M |
| March 31, 2022 | 2.932M |
| December 31, 2021 | -1.528M |
| September 30, 2021 | -7.565M |
| June 30, 2021 | -10.38M |
| March 31, 2021 | -7.663M |
| December 31, 2020 | -3.571M |
| September 30, 2020 | 2.559M |
| June 30, 2020 | 4.38M |
| March 31, 2020 | 1.759M |
| Date | Value |
|---|---|
| December 31, 2019 | 3.192M |
| September 30, 2019 | 2.626M |
| June 30, 2019 | 1.942M |
| March 31, 2019 | 3.244M |
| December 31, 2018 | 2.576M |
| September 30, 2018 | 1.407M |
| June 30, 2018 | 2.162M |
| March 31, 2018 | 2.207M |
| December 31, 2017 | 2.787M |
| September 30, 2017 | 3.585M |
| June 30, 2017 | 2.597M |
| March 31, 2017 | 0.981M |
| December 31, 2016 | -0.799M |
| September 30, 2016 | -0.949M |
| June 30, 2016 | -1.513M |
| March 31, 2016 | -1.499M |
| December 31, 2015 | -1.426M |
| September 30, 2015 | -2.159M |
| June 30, 2015 | -1.083M |
| March 31, 2015 | -0.793M |
| December 31, 2014 | 0.21M |
| September 30, 2014 | 0.483M |
| June 30, 2014 | -0.484M |
| March 31, 2014 | -0.429M |
| December 31, 2013 | -1.219M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 7.378B |
| AngioDynamics, Inc. | -3.534M |
| Alphatec Holdings, Inc. | -0.782M |
| AtriCure, Inc. | 53.64M |
| Baxter International, Inc. | 714.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.633M |
| Cash from Investing (Quarterly) | -5.055M |
| Cash from Financing (Quarterly) | 5.462M |
| Free Cash Flow Per Share (Quarterly) | 0.4652 |
| Free Cash Flow to Equity (Quarterly) | -7.238M |
| Free Cash Flow to Firm (Quarterly) | 1.669M |
| Free Cash Flow Yield | 3.22% |